Toll-like receptor 7 is required for effective adaptive immune responses that prevent persistent virus infection.
about
The germinal center antibody response in health and diseaseMyalgic Encephalomyelitis: Symptoms and BiomarkersAdvanced vaccine candidates for Lassa feverIntact dendritic cell pathogen-recognition receptor functions associate with chronic hepatitis C treatment-induced viral clearanceType I interferon is a therapeutic target for virus-induced lethal vascular damage.Platelet-TLR7 mediates host survival and platelet count during viral infection in the absence of platelet-dependent thrombosis.Toll-like receptor 9 signaling acts on multiple elements of the germinal center to enhance antibody responses.Early virus-host interactions dictate the course of a persistent infectionNegative feedback circuit for toll like receptor-8 activation in human embryonic Kidney 293 using outer membrane vesicle delivered bi-specific siRNA.Lymphocytic Choriomeningitis Virus Differentially Affects the Virus-Induced Type I Interferon Response and Mitochondrial Apoptosis Mediated by RIG-I/MAVS.Infected CD8α- dendritic cells are the predominant source of IL-10 during establishment of persistent viral infection.Critical role for interferon regulatory factor 3 (IRF-3) and IRF-7 in type I interferon-mediated control of murine norovirus replication.Pathogenesis of Lassa fever virus infection: I. Susceptibility of mice to recombinant Lassa Gp/LCMV chimeric virus.B Cell-intrinsic TLR7 signaling is required for optimal B cell responses during chronic viral infection.Inosine-mediated modulation of RNA sensing by Toll-like receptor 7 (TLR7) and TLR8.Baicalin inhibits TLR7/MYD88 signaling pathway activation to suppress lung inflammation in mice infected with influenza A virusA development that may evolve into a revolution in medicine: mRNA as the basis for novel, nucleotide-based vaccines and drugsThe role of toll-like receptors in B-cell development and immunopathogenesis of common variable immunodeficiency.Germinal centers and autoimmune disease in humans and mice.Nucleoprotein-specific nonneutralizing antibodies speed up LCMV elimination independently of complement and FcγR.Is the TAM receptor Axl a receptor for lymphocytic choriomeningitis virus?Porcine B Cell Subset Responses to Toll-like Receptor Ligands.Hematopoietic and nonhematopoietic cells promote Type I interferon- and TLR7-dependent monocytosis during low-dose LCMV infection.T-cell exhaustion due to persistent antigen: quantity not quality?Therapeutic recovery of hepatitis B virus (HBV)-induced hepatocyte-intrinsic immune defect reverses systemic adaptive immune tolerance.Novel Concepts for HIV Vaccine Vector Design.Co-Stimulation of BCR and Toll-Like Receptor 7 Increases Somatic Hypermutation, Memory B Cell Formation, and Secondary Antibody Response to Protein Antigen.TLRs/NLRs: Shaping the landscape of host immunity.Respiratory Influenza A Virus Infection Triggers Local and Systemic Natural Killer Cell Activation via Toll-Like Receptor 7.Toll-like receptors in lupus nephritis.CD22-Binding Synthetic Sialosides Regulate B Lymphocyte Proliferation Through CD22 Ligand-Dependent and Independent Pathways, and Enhance Antibody Production in Mice.Review of Biology and ReplicationLupus acceleration by a MAVS-activating RNA virus requires endosomal TLR signaling and host genetic predisposition
P2860
Q26745929-4F91819D-0205-4EF8-915A-6B2507117463Q26786545-C17200A3-6F34-4899-9378-7B7ECCD1B88BQ26823627-492123E9-A166-46F0-A144-62ADB4D11696Q28540848-472E0949-8431-44D9-B73D-D571360AE421Q33415686-AD381436-B4F2-45D0-994F-93AA3A398278Q33987093-432848EC-10A7-4C38-A295-B32ABB076A2AQ34025386-E3544A28-A4DC-4FF5-9E9A-699938B5582BQ34876341-4CEC4C7E-AF52-4641-86C2-970A550885D8Q35707013-E98D0E20-387D-4E26-8C95-74B0FAC88C6BQ35760477-4BB12452-0456-4FFF-9228-71B0A86C9D63Q36212828-2C5E1F5D-4AE1-49BB-80C2-1A516E52DF3FQ36414470-9754DE78-987C-4EDF-9214-04F15769FD61Q36941000-10E7230E-6859-42AE-8AE2-FC978B9EAC56Q36986093-354639D3-9B51-4086-A5CF-FEF18BCFFB92Q37547499-8BEB0183-41A8-48B1-BF52-AFF399E2775AQ37708471-A4121E86-432C-462F-851D-EB73D1CC9B4EQ38206520-6CEA9244-9D59-427F-AF61-CE1CDFD0BB02Q38665495-D1EBAEDC-1CB5-42F9-A759-2AA7EBB5E684Q38937343-D052881C-F55E-436D-9174-7F278E3E0111Q39142065-BA39141B-0804-46CC-80A3-05243DE115F9Q39788660-A0FC60C0-1E8A-4EE7-9E98-E5BAD4577B60Q40048525-48D279F0-CB5C-4D2E-A13C-0056A4BBE4E1Q41043644-0086C246-1144-4537-B383-E97BFD2CD2CDQ41841586-0EB98174-0FBA-4A3E-8ED2-8E72E00D12D2Q43435087-20D4A706-D7C6-4FAB-BFD6-C3D477A7CFA6Q47112156-BE684E6C-E222-427A-B598-43BC364ABEE9Q47221189-C0FCF2B7-5DDD-473C-B54F-718F7E3511E0Q47570715-9B5D51C7-DFD5-46DC-832D-284FA9792391Q50335684-75A1A612-EF56-49AE-AF55-44C834E360C1Q52323268-B3F9245F-A712-47E0-A272-D5484B43A71EQ54937363-6005B14D-73D1-4AD8-BD1D-80AACA1208C2Q56897476-5ED29781-2950-4B1B-BFAE-FCB41422808FQ57018427-6C765823-7BBB-4040-82C5-0B11E29CB283
P2860
Toll-like receptor 7 is required for effective adaptive immune responses that prevent persistent virus infection.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Toll-like receptor 7 is requir ...... nt persistent virus infection.
@ast
Toll-like receptor 7 is requir ...... nt persistent virus infection.
@en
type
label
Toll-like receptor 7 is requir ...... nt persistent virus infection.
@ast
Toll-like receptor 7 is requir ...... nt persistent virus infection.
@en
prefLabel
Toll-like receptor 7 is requir ...... nt persistent virus infection.
@ast
Toll-like receptor 7 is requir ...... nt persistent virus infection.
@en
P2093
P2860
P1433
P1476
Toll-like receptor 7 is requir ...... nt persistent virus infection.
@en
P2093
Daniel M Fremgen
E John Wherry
Elina I Zuniga
John R Teijaro
Karl F von Tiehl
Kevin B Walsh
Megan J Welch
Michael B A Oldstone
Richard A Flavell
Shawn D Blackburn
P2860
P304
P356
10.1016/J.CHOM.2012.04.016
P577
2012-06-01T00:00:00Z